Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 451

1.

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, Hengel H, Angulo A, Moretta A, López-Botet M.

Blood. 2011 Jan 20;117(3):848-56. doi: 10.1182/blood-2010-08-301374. Epub 2010 Oct 28.

PMID:
21030563
[PubMed - indexed for MEDLINE]
Free Article
2.

NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, Moretta A, Valiante NM, Parham P.

J Immunol. 2007 Mar 1;178(5):2688-98.

PMID:
17312110
[PubMed - indexed for MEDLINE]
Free Article
3.

Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.

Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C.

J Immunol. 2003 Jul 15;171(2):902-8.

PMID:
12847260
[PubMed - indexed for MEDLINE]
Free Article
4.

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.

El-Sherbiny YM, Meade JL, Holmes TD, McGonagle D, Mackie SL, Morgan AW, Cook G, Feyler S, Richards SJ, Davies FE, Morgan GJ, Cook GP.

Cancer Res. 2007 Sep 15;67(18):8444-9.

PMID:
17875681
[PubMed - indexed for MEDLINE]
Free Article
5.

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

Nielsen N, Pascal V, Fasth AE, Sundström Y, Galsgaard ED, Ahern D, Andersen M, Baslund B, Bartels EM, Bliddal H, Feldmann M, Malmström V, Berg L, Spee P, Söderström K.

Immunology. 2014 Aug;142(4):581-93. doi: 10.1111/imm.12271.

PMID:
24673109
[PubMed - indexed for MEDLINE]
6.

Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.

Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, Introna M.

Blood. 2011 Sep 22;118(12):3301-10. doi: 10.1182/blood-2011-02-336321. Epub 2011 Aug 5.

PMID:
21821703
[PubMed - indexed for MEDLINE]
Free Article
7.

HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.

Cederarv M, Söderberg-Nauclér C, Odeberg J.

Immunobiology. 2009;214(5):331-41. doi: 10.1016/j.imbio.2008.10.009. Epub 2009 Jan 18.

PMID:
19152985
[PubMed - indexed for MEDLINE]
8.

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T, Kanazawa Y, Hiramatsu N, Hayashi N.

J Immunol. 2004 Nov 15;173(10):6072-81.

PMID:
15528343
[PubMed - indexed for MEDLINE]
Free Article
9.

UL40-mediated NK evasion during productive infection with human cytomegalovirus.

Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5.

PMID:
12032324
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.

Garcia-Iglesias T, Del Toro-Arreola A, Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE, Ramirez-Dueñas MG, Balderas-Peña LM, Bravo-Cuellar A, Ortiz-Lazareno PC, Daneri-Navarro A.

BMC Cancer. 2009 Jun 16;9:186. doi: 10.1186/1471-2407-9-186.

PMID:
19531227
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection.

Muntasell A, Magri G, Pende D, Angulo A, López-Botet M.

Blood. 2010 Jun 24;115(25):5170-9. doi: 10.1182/blood-2009-11-256479. Epub 2010 Apr 14.

PMID:
20393128
[PubMed - indexed for MEDLINE]
Free Article
12.

NK cell receptors involved in the response to human cytomegalovirus infection.

Gumá M, Angulo A, López-Botet M.

Curr Top Microbiol Immunol. 2006;298:207-23. Review.

PMID:
16323417
[PubMed - indexed for MEDLINE]
13.

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

Gumá M, Budt M, Sáez A, Brckalo T, Hengel H, Angulo A, López-Botet M.

Blood. 2006 May 1;107(9):3624-31. Epub 2005 Dec 29.

PMID:
16384928
[PubMed - indexed for MEDLINE]
Free Article
14.

Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.

Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, Johnson DC, Cosman D.

J Exp Med. 2003 Jun 2;197(11):1427-39.

PMID:
12782710
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.

Al-Hubeshy ZB, Coleman A, Nelson M, Goodier MR.

J Immunol Methods. 2011 Mar 7;366(1-2):52-9. doi: 10.1016/j.jim.2011.01.007. Epub 2011 Jan 28. Erratum in: J Immunol Methods. 2011 Oct 28;373(1-2):252.

PMID:
21281644
[PubMed - indexed for MEDLINE]
16.

Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.

Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.

J Leukoc Biol. 2005 Aug;78(2):359-71. Epub 2005 Jun 3.

PMID:
15937142
[PubMed - indexed for MEDLINE]
Free Article
17.

Short-term exposure to human cytomegalovirus-infected fibroblasts induces a proportional increase of active CD94/NKG2A(+) natural killer cells.

Petersen L, Petersen CC, Møller-Larsen A, Hokland ME.

Hum Immunol. 2010 Jan;71(1):29-35. doi: 10.1016/j.humimm.2009.09.355. Epub .

PMID:
19782712
[PubMed - indexed for MEDLINE]
18.

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR.

J Immunol. 2008 Nov 15;181(10):6711-9.

PMID:
18981088
[PubMed - indexed for MEDLINE]
Free Article
19.

Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium.

Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, Safi H, Girard WM, Cosman D, Spies T, Barnes PF.

J Immunol. 2005 Oct 1;175(7):4611-7.

PMID:
16177106
[PubMed - indexed for MEDLINE]
Free Article
20.

NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.

Romero AI, Thorén FB, Brune M, Hellstrand K.

Br J Haematol. 2006 Jan;132(1):91-8.

PMID:
16371024
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk